Author:
Garrido Elena,Cormand Bru,Hopwood John J.,Chabás Amparo,Grinberg Daniel,Vilageliu Lluïsa
Subject
Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference34 articles.
1. Components and proteolytic processing sites of arylsulfatase B from human placenta;Kobayashi;Biochim. Biophys. Acta,1992
2. Mucopolysaccharidosis VI (Maroteaux–Lamy syndrome). An intermediate clinical phenotype caused by substitution of valine for glycine at position 137 of arylsulfatase B;Wicker;J. Biol. Chem.,1991
3. Mucopolysaccharidosis type VI: identification of three mutations in the arylsulfatase B gene of patients with the severe and mild phenotypes provides molecular evidence for genetic heterogeneity;Jin;Am. J. Hum. Genet.,1992
4. An N-acetylgalactosamine-4-sulfatase mutation delta G238 results in a severe Maroteaux–Lamy phenotype;Litjens;Hum. Mutat.,1992
5. Identification, expression, and biochemical characterization of N-acetylgalactosamine-4-sulfatase mutations and relationship with clinical phenotype in MPS-VI patients;Litjens;Am. J. Hum. Genet.,1996
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献